M
10b5-1 Plan
$ Value
$0
Shares
7,920
Price
$0
Filed
Dec 16
Insider
Name
Castagna Michael
Title
Chief Executive Officer
CIK
0001674282
Roles
Director
Officer
Transaction Details
Transaction Date
2025-12-12
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Transaction occurred pursuant to Rule 10b5-1 Plan established August 8, 2025.
Filing Info
Castagna Michael's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-23 | MNKD | A | $0 |
| 2026-03-23 | MNKD | A | $0 |
| 2025-12-24 | MNKD | G | $0 |
| 2025-12-17 | MNKD | M | $299K |
| 2025-12-17 | MNKD | ▼ | $395K |
| 2025-12-17 | MNKD | M | $0 |
| 2025-12-17 | MNKD | M | $0 |
| 2025-12-16 | MNKD | M | $97K |
| 2025-12-16 | MNKD | ▼ | $128K |
| 2025-12-16 | MNKD | M | $0 |
Other Insiders at MNKD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Thomson David
EVP Genl Counsel & Secretary
|
— | — | 2026-03-23 |
|
Tross Stuart A
Chief People & Workpl Officer
|
— | — | 2026-03-23 |
|
Castagna Michael
Chief Executive Officer
|
— | — | 2026-03-23 |
|
Prentiss Christopher B
Chief Financial Officer
|
— | — | 2026-03-23 |
|
Singh Sanjay R
EVP Technical Operations
|
— | — | 2026-03-23 |
|
Ahuja Ajay
Chief Medical Officer
|
— | — | 2026-03-23 |